STOCK TITAN

Blue Owl Capital Corporation III - $OBDE STOCK NEWS

Welcome to our dedicated page for Blue Owl Capital Corporation III news (Ticker: $OBDE), a resource for investors and traders seeking the latest updates and insights on Blue Owl Capital Corporation III stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Blue Owl Capital Corporation III's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Blue Owl Capital Corporation III's position in the market.

Rhea-AI Summary
Blue Owl Capital III (OBDE) announced the release of its financial results for the first quarter of 2024 on May 8, 2024, with a webcast/conference call scheduled for May 9, 2024, to discuss the results. Interested parties can join the call by visiting OBDE's website or dialing the provided numbers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
-
Rhea-AI Summary
Blue Owl Capital Corporation III (OBDE) reported strong financial results for the full year and fourth quarter of 2023, showcasing record net investment income and dividend per share. The company's NII ROE increased to 15.1% in Q4'23, up from 12.9% in Q4'22. Additionally, OBDE declared a first quarter 2024 dividend of $0.35 per share and approved a $100 million stock repurchase program. The portfolio and investing activity saw new investment commitments totaling $596.5 million for the full year 2023, with an increased NAV per share to $15.56. Despite two portfolio companies on non-accrual status, OBDE remains optimistic about delivering attractive risk-adjusted returns for shareholders in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
none
-
Rhea-AI Summary
Blue Owl Capital Corporation III (OBDE) has received approval from the New York Stock Exchange and is expected to commence trading under the ticker symbol 'OBDE'. Preliminary Q4 2023 estimates show a net investment income per share range of $0.56 to $0.59 and a net asset value per share range of $15.52 to $15.58. Full financial results for Q4 and year ended December 31, 2023, will be released on February 21, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.23%
Tags
none
Rhea-AI Summary
Blue Owl Capital Corporation III (OBDE), a leading business development company focused on lending to U.S. upper middle-market companies, intends to list its shares of common stock on the NYSE. The company plans to disclose preliminary estimates of fourth-quarter 2023 results by January 24, 2024, and release full financial results for the fourth quarter and fiscal year 2023 on February 21, 2024. The board declared a first quarter 2024 regular dividend of $0.35 per share and five special dividends of $0.06 per share, payable on a quarterly basis. A share repurchase program of up to $100 million of outstanding common stock has been approved. The board also waived transfer restrictions for a portion of the company's common stock. BofA Securities, J.P. Morgan, and RBC Capital Markets are serving as lead advisors to the company in connection with its proposed listing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.58%
Tags
none
Blue Owl Capital Corporation III

NYSE:OBDE

OBDE Rankings

OBDE Stock Data

1.93B
123.13M
United States of America
NEW YORK